Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Istvan M Majer

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
JAMA|August 14, 2019
Time Horizons in Cost AnalysesIstvan M Majer, Shaji K Kumar, Stephen Palmer
Statistics in Medicine|August 18, 2012
Time trends and forecasts of body mass index from repeated cross-sectional data: a different approachIstvan M Majer, Johan P Mackenbach, Pieter H M van Baal
Journal of Market Access & Health Policy|April 29, 2016
Efficacy, tolerability, and safety of aripiprazole once-monthly versus other long-acting injectable antipsychotic therapies in the maintenance treatment of schizophrenia: a mixed treatment comparison of double-blind randomized clinical trialsIstvan M Majer, Fiona Gaughran, Christophe Sapin, et al.
Pharmacoeconomics|January 6, 2019
Modeling Covariate-Adjusted Survival for Economic Evaluations in OncologyIstvan M Majer, Jean-Gabriel Castaigne, Stephen Palmer, et al.
Obesity (Silver Spring, Md.)|March 19, 2011
Life expectancy and life expectancy with disability of normal weight, overweight, and obese smokers and nonsmokers in EuropeIstvan M Majer, Wilma J Nusselder, Johan P Mackenbach, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 17, 2015
Which factors enhance positive drug reimbursement recommendation in Scotland? A retrospective analysis 2006-2013Mata Charokopou, Istvan M Majer, Johan de Raad, et al.
Plos Neglected Tropical Diseases|November 13, 2010
Cost-effectiveness of a chemoprophylactic intervention with single dose rifampicin in contacts of new leprosy patientsWillemijn J Idema, Istvan M Majer, David Pahan, et al.
Medical Care|March 14, 2012
Forecasting lifetime and aggregate long-term care spending: accounting for changing disability patternsClaudine A M de Meijer, Istvan M Majer, Marc A Koopmanschap, et al.
American Journal of Public Health|October 25, 2011
Mortality risk associated with disability: a population-based record linkage studyIstvan M Majer, Wilma J Nusselder, Johan P Mackenbach, et al.
Demography|October 30, 2012
Modeling and forecasting health expectancy: theoretical framework and applicationIstvan M Majer, Ralph Stevens, Wilma J Nusselder, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
JAMA|August 14, 2019
Time Horizons in Cost AnalysesIstvan M Majer, Shaji K Kumar, Stephen Palmer
Statistics in Medicine|August 18, 2012
Time trends and forecasts of body mass index from repeated cross-sectional data: a different approachIstvan M Majer, Johan P Mackenbach, Pieter H M van Baal
Journal of Market Access & Health Policy|April 29, 2016
Efficacy, tolerability, and safety of aripiprazole once-monthly versus other long-acting injectable antipsychotic therapies in the maintenance treatment of schizophrenia: a mixed treatment comparison of double-blind randomized clinical trialsIstvan M Majer, Fiona Gaughran, Christophe Sapin, et al.
Pharmacoeconomics|January 6, 2019
Modeling Covariate-Adjusted Survival for Economic Evaluations in OncologyIstvan M Majer, Jean-Gabriel Castaigne, Stephen Palmer, et al.
Obesity (Silver Spring, Md.)|March 19, 2011
Life expectancy and life expectancy with disability of normal weight, overweight, and obese smokers and nonsmokers in EuropeIstvan M Majer, Wilma J Nusselder, Johan P Mackenbach, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 17, 2015
Which factors enhance positive drug reimbursement recommendation in Scotland? A retrospective analysis 2006-2013Mata Charokopou, Istvan M Majer, Johan de Raad, et al.
Plos Neglected Tropical Diseases|November 13, 2010
Cost-effectiveness of a chemoprophylactic intervention with single dose rifampicin in contacts of new leprosy patientsWillemijn J Idema, Istvan M Majer, David Pahan, et al.
Medical Care|March 14, 2012
Forecasting lifetime and aggregate long-term care spending: accounting for changing disability patternsClaudine A M de Meijer, Istvan M Majer, Marc A Koopmanschap, et al.
American Journal of Public Health|October 25, 2011
Mortality risk associated with disability: a population-based record linkage studyIstvan M Majer, Wilma J Nusselder, Johan P Mackenbach, et al.
Demography|October 30, 2012
Modeling and forecasting health expectancy: theoretical framework and applicationIstvan M Majer, Ralph Stevens, Wilma J Nusselder, et al.
Pageof 1